AMORPHOUS And SemiCRYSTALLINE TROGAMID®
Glassclear and highly resistant
With the takeover of the Chemicals division of Dynamit Nobel AG in 1988, Evonik acquired the transparent, amorphous polyamide TROGAMID® T. Dynamit Nobel launched this first polymer of dimethyl terephthalate and trimethylhexamethylene diamine on the market as early as 1968. Substitution of the aromatic components by aliphatic monomers led in 1991 to transparent polyamides with inherently better UV resistance. Systematic selection of the cycloaliphatic diamine and 1,12-dodecanedioic acid monomers resulted in a crystallizable, permanently transparent polyamide, distinguished as crystalline by the name TROGAMID® CX, in 1995.
Nomenclature ISO 1043
Nomenclature ISO 1874
trimethyl hexamethylene diamine terephthalic acid
PA PACM 12
cycloaliphatic diamine dodecanedioic acid
Common transparent polyamides consist
in partially aromatic units that impart rigidity and high heat resistance. Our TROGAMID® T compounds are typical representatives of this group.
Replacing aromatic constituents with aliphatic monomers improves the UV stability of transparent polyamides. TROGAMID® CX7323 is an example of this type of polyamides. By selecting specific monomers the crystallites are so small that they do not scatter visible light, and the material appears transparent to the human eye—a property known as microcrystallinity.
TROGAMID® Care compounds were subject to specific evaluation. They are based on the semi-crystalline compounds.